Clinical TrialsSearch results
Number of results: 891
Other
- Phase II study of micafungin as empirical antifungal therapy for febrile neutropenic patients (C-SHOT 0503 study)
- Febrile neutropenia
- Center for Supporting Hematology-Oncology Trials (C-SHOT)
- 2006-03-30
Other
- Phase II study of imatinib mesylate for treatment of Philadelphia Chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in children: A Japanese Cooperative Trial
- Philadelphia Chromosome-positive acute lymphoblastic leukemia
- Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)
- 2005-12-01
Other
- Phase II study of gemcitabine alone in locally advanced pancreatic cancer: Japan Clinical Oncology Group Study (JCOG 0506)
- pancreatic neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2006-01-19
Recruiting
- Phase II study of concurrent intensity modulated radiation therapy with docetaxel, cisplatin and 5-FU for advanced squamous cell carcinoma of cervical esophagus in Japan
- Esophageal cancer
- Watanabe Akinori
- 2021-04-01
Recruiting
- Phase II study of combination chemotherapy with S-1 plus Avastin in unresectable or recurrent colorectal cancer after failure of prior chemotherapy, including irinotecan and oxaliplatin regimens.
- colorectal cancer
- Translational Research Informatics Center(TRI)
- 2009-08-07
Other
- Phase II study of combination chemotherapy and high-dose chemotherapy in treating young children with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumors
- medulloblastoma or supratentorial primitive neuroectodermal tumors
- Japanese Pediatric Brain Tumor Consortium
- 2006-12-08
Other
- Phase II study of Chemotherapy for Advanced or Recurrent Thymoma
- Thymoma (excluding thymic carcinoma)
- Japanese Association for Research on the Thymus
- 2006-04-01
Other
- Phase II Study of bi-weekly Paclitaxel (TAXOL)for fluorouracil resistant advanced and recurrent Gastric Cancer
- 5-fluorouracil resistant advanced and recurrent Gastric Cancer
- The Tokyo Cooperative Oncology Group
- 2005-11-18
Other
- Phase II study of Bevacizumab plus modified OPTIMOX1 in patients with unresectable advanced/recurrent colorectal cancer
- Unresectable advanced/recurrent colorectal cancer
- The Tokyo Cooperative Oncology Group
- 2008-06-01
Other
- Phase II study of ABVd therapy for the previously untreated patients with stage II to IV Hodgkin' s disease (JCOG 9305, LSG14)
- previouly untreated advanced stage Hodgkin lymphoma (stage II, III, IVy)
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30